Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Tuberculosis.

Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C.

Lancet. 2003 Sep 13;362(9387):887-99. Review.

PMID:
13678977
2.

Tuberculosis: current trends in diagnosis and treatment.

Bello AK, Njoku CH.

Niger J Clin Pract. 2005 Dec;8(2):118-24. Review. Erratum in: Niger J Clin Pract. 2006 Jun;9(1):94. Bello, AK [added]; Njoku, AK [corrected to Njoku, CH].

PMID:
16477867
3.
4.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
5.

Tuberculosis and human immunodeficiency virus infection in developing countries.

Harries AD.

Lancet. 1990 Feb 17;335(8686):387-90. Review.

PMID:
1968123
6.

Control of tuberculosis by community health workers in Bangladesh.

Chowdhury AM, Chowdhury S, Islam MN, Islam A, Vaughan JP.

Lancet. 1997 Jul 19;350(9072):169-72. Erratum in: Lancet 1997 Oct 11;350(9084):1108.

PMID:
9250184
8.

[Tuberculosis in Asia].

[No authors listed]

Kekkaku. 2002 Oct;77(10):693-7. Japanese.

PMID:
12440145
9.

Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review.

Steingart KR, Henry M, Laal S, Hopewell PC, Ramsay A, Menzies D, Cunningham J, Weldingh K, Pai M.

PLoS Med. 2007 Jun;4(6):e202. Review. Erratum in: PLoS Med. 2007 Aug;4(8):e254.

10.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
11.

Tuberculosis and HIV disease: two decades of a dual epidemic.

Aliyu MH, Salihu HM.

Wien Klin Wochenschr. 2003 Oct 31;115(19-20):685-97. Review.

PMID:
14650943
12.
13.

Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.

Hanrahan CF, Selibas K, Deery CB, Dansey H, Clouse K, Bassett J, Scott L, Stevens W, Sanne I, Van Rie A.

PLoS One. 2013 Jun 6;8(6):e65421. doi: 10.1371/journal.pone.0065421. Print 2013.

14.

Tuberculosis programme changes and treatment outcomes in patients with smear-positive pulmonary tuberculosis in Blantyre, Malawi.

Harries AD, Nyong'Onya Mbewe L, Salaniponi FM, Nyangulu DS, Veen J, Ringdal T, Nunn P.

Lancet. 1996 Mar 23;347(9004):807-9.

PMID:
8622340
15.

Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.

Parikh R, Nataraj G, Kanade S, Khatri V, Mehta P.

J Assoc Physicians India. 2012 Aug;60:22-6.

PMID:
23405517
16.

Women and tuberculosis.

Connolly M, Nunn P.

World Health Stat Q. 1996;49(2):115-9. Review.

PMID:
9050189
17.

[Reconsideration of the admission and discharge criteria of tuberculosis patients in Japan].

Masuyama H, Igari H.

Kekkaku. 2013 Mar;88(3):373-85. Japanese.

PMID:
23672177
18.

Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection.

El-Sony AI, Khamis AH, Enarson DA, Baraka O, Mustafa SA, Bjune G.

Int J Tuberc Lung Dis. 2002 Dec;6(12):1058-66.

PMID:
12546113
19.

What is the limit to case detection under the DOTS strategy for tuberculosis control?

Dye C, Watt CJ, Bleed DM, Williams BG.

Tuberculosis (Edinb). 2003;83(1-3):35-43.

PMID:
12758187
20.

Tuberculosis control in Bangladesh: success of the DOTS strategy.

Kumaresan JA, Ahsan Ali AK, Parkkali LM.

Int J Tuberc Lung Dis. 1998 Dec;2(12):992-8.

PMID:
9869115

Supplemental Content

Support Center